Bob Knarr

Biography

Mr. Knarr joined Mederi as CEO on October 1, 2015. A specialist in medical device growth and development, Mr. Knarr was part of the executive team at US Surgical that drove revenue growth from less than $10 million to more than $1.5 billion. His roles at USSC grew from 1977, as a sales representative, to 1998 as President of North American Operations, he also served as a member of the Board of Directors of USSC. He most recently was a founding partner of JHK investments, a medical device focused venture capital firm led by the founders of US Surgical. Their portfolio of products and companies included interventional cardiology (Angiolink, Jarvik Heart, Interventional Therapies), Cryogen, Biowave pain management products, and Vivatone Hearing Aid Systems.

Research Interest

Business Development